Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Study links corneal nerve loss, immune activation, and stem cell deficiency in neurotrophic keratitis
  • Neurotrophic Keratitis

Study links corneal nerve loss, immune activation, and stem cell deficiency in neurotrophic keratitis

Kelsey Moroz

Neurotrophic keratitis (NK) is associated with linked damage to corneal nerves, limbal epithelial stem cells (LESCs), and immune activation, according to a study.

The study included 54 patients with neurotrophic keratitis (55 eyes) and 57 healthy controls (59 eyes). In vivo confocal microscopy (IVCM) was used to assess subbasal corneal nerve fiber density (CNFD), corneal nerve fiber length (CNFL), corneal nerve branch density (CNBD), limbal epithelial basal cell (LEBC) density in multiple directions, and dendritic cell (DC) status. In a subgroup treated with recombinant human nerve growth factor (rhNGF) (7 eyes of 7 patients), measurements were recorded at baseline, weeks 4 and 8, and at a 2-year follow-up.

Key findings compared with healthy controls:

  • CNFD, CNFL, and CNBD were significantly lower in patients with NK (all P < 0.01).
  • Central basal cell density and peripheral LESC density were markedly reduced (both P < 0.001).
  • DC density and DC activation ratio were significantly higher in the NK group (both P < 0.001).

Key correlations in the NK group:

  • CNFD was positively correlated with LESC density (P = 0.46; P < 0.001).
  • CNFD was negatively correlated with fluorescein staining scores (P = −0.46; P < 0.001).
  • CNFD was negatively correlated with DC density (P = −0.57; P < 0.001).
  • LESC density was negatively correlated with fluorescein staining scores (P = −0.62; P < 0.001).
  • LESC density was negatively correlated with mean DC area (P = −0.44; P < 0.001).
  • Fluorescein staining scores were positively correlated with DC density (P = 0.44; P < 0.001).

In the rhNGF-treated subgroup, improvements in LESC density, DC density, DC activation, and fluorescein staining scores were observed by week 4. Nerve regeneration became detectable after 8 weeks and showed significant recovery by the 2-year follow-up.

Reference

Yan Y, Yang Z, Deng Q, Cheng S, Wan S, Pan J, Huang L, Yang Y. Association between Neurotrophic Keratitis and Limbal Stem Cell Deficiency. Am J Ophthalmol. 2026;S0002-9394(26)00029-2. doi: 10.1016/j.ajo.2026.01.021. Epub ahead of print. PMID: 41617121.

Share

Related Content

  • Neurotrophic Keratitis

Autologous serum eye drops improve symptoms and corneal nerve parameters in neurotrophic keratitis

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

  • Neurotrophic Keratitis

Systemic abnormalities commonly found in neurotrophic keratopathy patients, study finds

  • Neurotrophic Keratitis

Novel anterior keratoplasty approach supports healing in refractory ocular surface disease

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon